Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zenas BioPharma (ZBIO) Other financing activities (2024 - 2025)

Zenas BioPharma (ZBIO) has 1 years of Other financing activities data on record, last reported at $4.5 million in Q4 2024.

  • For Q4 2024, Other financing activities changed N/A year-over-year to $4.5 million; the TTM value through Dec 2024 reached $6.3 million, changed N/A, while the annual FY2024 figure was $6.3 million, N/A changed from the prior year.
  • Other financing activities reached $4.5 million in Q4 2024 per ZBIO's latest filing, up from $439000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $4.5 million in Q4 2024 and bottomed at $439000.0 in Q3 2024.